Medicine and Dentistry
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Biosimilar
54%
Etanercept
42%
Infliximab
29%
Abatacept
27%
Cohort Study
25%
Tumor Necrosis Factor
24%
Spondylarthritis
23%
C Reactive Protein
21%
DAS28
19%
Disease Activity
17%
Observational Study
17%
Infection
17%
Outpatient
16%
TNF Inhibitor
16%
Gene Linkage
16%
Rheumatic Disease
15%
Keyphrases
DANBIO Registry
49%
Rheumatoid Arthritis
48%
Etanercept
42%
Biosimilar
40%
Sweden
28%
Clinical Practice
28%
Inflammatory Arthritis
27%
Non-medical Switching
27%
Abatacept
27%
Tocilizumab
27%
Routine Care
20%
C-reactive Protein
17%
Finland
16%
Iceland
16%
Tumour Necrosis Factor Inhibitor (TNFi)
16%
Denmark
16%
Disease Activity Score 28 (DAS28)
15%
Treatment Retention
15%
Data Protection
15%
Infliximab
15%